SEC Form 4 · accession 0001354488-16-006460
Cellular Biomedicine Group, Inc. · CBMG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wei (William) Cao
Director
Period of report
Mar 2, 2016
Accepted (ET)
Mar 4, 2016 · 7:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001378624
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 2, 2016 | M | 7,500 | $5.40 | A | 181,972 | D | |
| Common Stock | Mar 2, 2016 | S | 7,500 | $17.55 | D | 174,472 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non- Qualified Stock Option (right to buy) (2013 Plan)F2 | $5.40 | Mar 2, 2016 | M | 7,500 | A | — | Sep 30, 2023 | Common Stock | 7,500 | 42,500 | D |
Explanation of responses
- F1The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
- F2The option vests according to the following schedule: 1/36th per month following the vesting commencement date of September 30, 2013.